337
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Preparation and optimization of acetaminophen nanosuspension through nanoprecipitation using microfluidic devices: an artificial neural networks study

, , , &
Pages 609-618 | Received 19 Oct 2011, Accepted 05 Dec 2011, Published online: 19 Jan 2012

References

  • Chingunpituk J. Nanosuspension technology for drug delivery. Walailak J Sci & Tech 2007;4:139–153.
  • Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 2004;56:827–840.
  • Krishna KB, Prabhakar C. A review on nanosuspensions in drug delivery. Int J Pharma Bio sciences 2011;2:549–558.
  • Weibel DB, Whitesides GM. Applications of microfluidics in chemical biology. Curr Opin Chem Biol 2006;10:584–591.
  • Peppas NA, Hilt JZ, Thomas JB. Nanotechnology in Therapeutics: Current Technology and Applications. Wymondham: Taylor & Francis; 2007.
  • Miyazaki M, Honda T, Yamaguchi H, Briones MP, Maeda H. Enzymatic processing in microfluidic reactors. Biotechnol Genet Eng Rev 2008;25:405–428.
  • Voldman J, Gray ML, Schmidt MA. Microfabrication in biology and medicine. Annu Rev Biomed Eng 1999;1:401–425.
  • Maiellaro PA, Cozzolongo R, Marino P. Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C. Curr Pharm Des 2004;10:2101–2109.
  • Mantri JK, Gahan P, Nayak BB. Artificial neural networks− an application to stock market volatility. Int J Eng Sci Technol 2010;2:1451–1460.
  • Lek S, Guégan JF. Artificial neural networks as a tool in ecological modelling, an introduction. Ecol Modell 1999;120:65–73.
  • Maier HR, Dandy GC. Neural networks for the prediction and forecasting of water resources variables: a review of modelling issues and applications. Environ Model Software 2000;15:101–24.
  • Amani A, Mohammadyani D. Artificial Neural Networks: Applications in Nanotechnology. In: Hui C-L ( ed.)Artificial neural networks − application. Rijeka: INTECH; 2011. Available at: http://www.intechopen.com/articles/show/title/artificial-neural-networks-applications-in-nanotechnology
  • Shao Q, Rowe RC, York P. Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation. Eur J Pharm Sci 2006;28:394–404.
  • Amani A, York P, Chrystyn H, Clark BJ, Do DQ. Determination of factors controlling the particle size in nanoemulsions using Artificial Neural Networks. Eur J Pharm Sci 2008;35:42–51.
  • Ali HS, Blagden N, York P, Amani A, Brook T. Artificial neural networks modelling the prednisolone nanoprecipitation in microfluidic reactors. Eur J Pharm Sci 2009;37:514–522.
  • Olden JD, Jackson DA. Illuminating the” black box”: a randomization approach for understanding variable contributions in artificial neural networks. Ecol Model 2002;154:135–150.
  • Müller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3–19.
  • Bodmeier R, Huagang C. Indomethacin polymeric nanosuspensions prepared by microfluidization. J Control Release 1990;12:223–233.
  • Pignatello R, Ricupero N, Bucolo C, Maugeri F, Maltese A, Puglisi G. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS PharmSciTech 2006;7:E27.
  • Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. Langmuir 2007;23:9866–9874.
  • Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 2011;63:456–469.
  • Chingunpitak J, Puttipipatkhachorn S, Chavalitshewinkoon-Petmitr P, Tozuka Y, Moribe K, Yamamoto K. Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method. Drug Dev Ind Pharm 2008;34:314–322.
  • Ain-Ai A, Gupta PK. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int J Pharm 2008;351:282–288.
  • Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P, Van den Mooter G. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion. Eur J Pharm Sci 2008;35:127–135.
  • Koteshwara KB, Reddy MS, Anup N, Madhavan N. Nanosuspesnions: a novel drug delivery approach. Int J research ayurveda Pharma 2011;2:162–165.
  • Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2007;2:16.
  • Zhao H, Wang JX, Wang QA, Chen JF, Yun J. Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor. Ind Eng Chem Res 2007;46:8229–8235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.